Your Cart ( 7 Items )

• Topical Agents Currently in Phase II or Phase III Trials for Atopic Dermatitis
  October 2020 | Volume 19 | Issue 10 | Original Article | 956 | Copyright © October 2020
  Shelley K. Uppal BS^a, Vipawee S. Chat BA^b, Donovan G. Kearns BS^c, Jashin J. Wu MD^d
  You will have 48 hours to download the full-text PDF

  Price

  24.95

  Term

  48 Hrs
• Comparative Study of the Efficacy and Tolerability of a Unique Topical Scar Product vs White Petrolatum Following Shave Biopsies
  January 2013 | Volume 12 | Issue 1 | Original Article | 86 | Copyright © January 2013
  Leon H. Kircik MD
  You will have 48 hours to download the full-text PDF

  Price

  24.95

  Term

  48 Hrs
• Topical Formulation Engendered Alteration in p53 and Cyclobutane Pyrimidine Dimer Expression in Chronic Photodamaged Patients
  March 2013 | Volume 12 | Issue 3 | Original Article | 336 | Copyright © March 2013
  James M. Spencer MD MS,^a Summer D. Moon BS,^b Kara M. Trapp BA,^c and Michael B. Morgan MD^d-f
  You will have 48 hours to download the full-text PDF

  Price

  24.95

  Term

  48 Hrs
• Short-Term Safety Assessment of Clobetasol Propionate 0.05% Shampoo: Hypothalamic–Pituitary–Adrenal Axis Suppression, Atrophogenicity, and Ocular Safety in Subjects with Scalp Psoriasis
  April 2006 | Volume 5 | Issue 4 | Original Article | 328 | Copyright © April 2006
  Philippe Andres MD, Michel Poncet MS, Farzaneh Sidou MS, Pascale Soto Pharm D
  You will have 48 hours to download the full-text PDF

  Price

  24.95

  Term

  48 Hrs
• Safety and Efficacy Evaluation of Tretinoin Cream 0.02% for the Reduction of Photodamage: A Pilot Study
  January 2012 | Volume 11 | Issue 1 | Original Article | 83 | Copyright © January 2012
  

  Leon H. Kircik MD

  Mount Sinai Medical Center, New York, NY Indiana University School of Medicine, Indianapolis, IN

  
  You will have 48 hours to download the full-text PDF

  Price

  24.95

  Term

  48 Hrs
• The Safety of Ustekinumab in Psoriasis
  August 2012 | Volume 11 | Issue 8 | Original Article | 907 | Copyright © August 2012
  

  Shannon Famenini BS^a and Jashin J. Wu MD^b

  ^aDavid Geffen School of Medicine at UCLA, Los Angeles, CA ^bDepartment of Dermatology, Kaiser Permanente Medical Center, Los Angeles, CA

  
  You will have 48 hours to download the full-text PDF

  Price

  24.95

  Term

  48 Hrs
• Hydrogen Peroxide Topical Solution, 45% for Common Warts: Phase 2 Efficacy and Safety Trial Results
  October 2020 | Volume 19 | Issue 10 | Original Article | 969 | Copyright © October 2020
  Stacy R. Smith MD^a, Stephen K. Tyring MD PhD^b, Kimberly K. Grande MD^c, Joel Schlessinger MD^d, Michael H. Gold MD^e, Stuart D. Shanier MD FAAD FACMS^f
  You will have 48 hours to download the full-text PDF

  Price

  24.95

  Term

  48 Hrs